A significant rise in chikungunya cases has been reported in southern China, with over 7,000 confirmed infections across several cities. The outbreak, which began in late July 2023, is primarily concentrated in the Shunde district of Foshan. The World Health Organization alerted the global community in July about the potential for a widespread chikungunya epidemic, emphasizing the need for immediate preventive measures.
Understanding Chikungunya and Its Spread
Chikungunya is a viral disease transmitted through bites from infected mosquitoes, specifically the dengue mosquito and the Asian tiger mosquito. The virus does not spread directly from person to person but requires a mosquito vector. Outbreaks are most common in regions of South-East Asia and parts of Africa, with the first identification of the virus occurring in Tanzania in 1952. Since then, it has been documented in more than 110 countries.
Symptoms of chikungunya typically manifest between 3 to 7 days after a mosquito bite and often include fever, severe joint pain, fatigue, and rash. While the disease is rarely fatal, it can be more severe for individuals over 65 years, those with underlying health conditions such as high blood pressure, diabetes, or heart disease, and newborns.
Current Situation and Preventive Measures
In Australia, the risk of contracting chikungunya is primarily associated with international travel to infected regions. Although mosquitoes capable of transmitting chikungunya are present in northern Queensland and the Torres Strait, the virus has not been detected in Australian mosquitoes to date.
Currently, no specific treatment exists for chikungunya, but pain relief medications can alleviate symptoms. It is crucial for individuals diagnosed with chikungunya to avoid mosquito bites while symptomatic to prevent further transmission.
Preventive measures include the use of physical barriers such as screen doors, mosquito nets, and applying insect repellent to exposed skin. Two vaccines have been approved in some countries, including the United States and the United Kingdom, but they are not available in Australia. The US Centers for Disease Control and Prevention is considering issuing a travel advisory for China in light of the rising case numbers.
The Chinese government has implemented measures reminiscent of those used during the COVID-19 pandemic. Patients are being isolated in hospital settings equipped with mosquito nets, while health officials conduct home inspections to identify and eliminate sources of stagnant water, which can breed mosquitoes. The Chinese Center for Disease Control and Prevention has issued guidelines to prevent chikungunya and dengue fever, which are both mosquito-borne diseases.
Local authorities in Guangdong are taking additional steps to manage the outbreak. Reports indicate that they have increased the number of mosquito-proof isolation beds to 7,220 in response to the growing demand. Furthermore, the Health Commission in Foshan announced that residents could face fines of up to 10,000 yuan (approximately $2,163.05) for failing to eliminate standing water on their properties.
As the situation evolves, health officials continue to monitor the outbreak closely, encouraging individuals displaying symptoms such as fever, rash, and joint pain to seek medical attention promptly.
